Top Markets
Coin of the day
SeqLL Inc. SeqLL Inc.

SeqLL Inc.

SQL
Rangering i aksjer #17414
Globally, SeqLL Inc. operates as a life sciences enterprise, providing... Globally, SeqLL Inc. operates as a life sciences enterprise, providing specialized instrumentation and research services. The company's primary focus involves the innovation, refinement, and production of cutting-edge genetic analysis technologies. Among its key offerings is the proprietary true single molecule sequencing (tSMS) platform, which facilitates the direct sequencing of DNA and RNA at the individual molecular level. SeqLL has established collaborative agreements with a range of esteemed organizations, including Bernstein Laboratory, Ting Laboratory, The Jackson Laboratory for Genomic Medicine, Weizmann Institute of Science, True Bearing Diagnostics, Inc., and Tetracore, Inc. Its diverse clientele encompasses academic institutions, governmental agencies, hospitals and medical centers, pharmaceutical and biotechnology companies, and various non-profit research groups. Established in 2013, the company maintains its headquarters in Billerica, Massachusetts.
Aksjekurs
$6.60
Sist synkronisert: 2025-02-06
Markedsverdi
$242.77M
Endring (1 dag)
0.00%
Endring (1 år)
0.00%
Land
US
Handel SeqLL Inc. (SQL)

Kategori

P/B-forhold for SeqLL Inc. (SQL)
P/B-forhold per 2026 TTM: 0
Ifølge SeqLL Inc. sine siste finansielle rapporter og aksjekurs er selskapets nåværende P/B-forhold (TTM) 0. Ved slutten av 2026 hadde selskapet et P/B-forhold på 0.
P/B-historikk for SeqLL Inc. fra 2026 til 2026
P/B-forhold ved hvert års slutt
År P/B-forhold Endre
Ikke nok data for de angitte datoene.
P/B-forhold for lignende selskaper eller konkurrenter
Selskap P/B-forhold Forskjell i P/B-forhold Land
4.346 -
US
2.8646 -
US
- -
CN
25.3254 -
US
7.0768 -
US